Poly-3-hydroxyalkanoates ͑PHAs͒ are synthesized by many bacteria as intracellular storage material. The final step in PHA biosynthesis is catalyzed by two PHA polymerases ͑phaC͒ in Pseudomonas putida. The expression of these two phaC genes ͑phaC1 and phaC2͒ was studied in Escherichia coli, either under control of the native promoter or under control of an external promoter. It was found that the two phaC genes are not expressed in E. coli without an external promoter. During heterologous expression of phaC from Plac on a high copy number plasmid, a rapid reduction of the number of colony forming units was observed, especially for phaC2. It appears that the plasmid instability was partially caused by high-level production of PHA polymerase. Subsequently, tightly regulated phaC2 expression systems on a low copy number vector were applied in E. coli. This resulted in PHA yields of over 20% of total cell dry weight, which was 2 fold higher than that obtained from the system where phaC2 is present on a high copy number vector. In addition, the PHA monomer composition differed when different gene expression systems or different phaC genes were applied.
Introduction
Medium chain length poly-3-hydroxyalkanoates ͑mcl-PHAs͒ accumulated by various bacteria are of increasing industrial interest because of their broad range of potential applications such as biodegradable plastics ͑Hänggi 1995; Page 1995͒, crosslinked biodegradable rubbers ͑de Koning and Witholt 1996͒, materials in medicine and pharmacy industries ͑Wil-liams et al. 1999͒, and sources of chiral monomers ͑Hrabak 1992͒. These biodegradable polymers can be produced from renewable substrates and therefore have the potential to replace chemically synthesized polymers, provided that the physiology, genetics, and biochemistry of the PHA-producing organisms are better understood.
Mcl-PHAs were first identified in Pseudomonas putida Gpo1 ͑earlier known as Pseudomonas oleovorans͒ grown on n-octane and other alkanes ͑de Smet et al. 1983; van Beilen et al. 2001͒ . It has been reported that the pha locus from P. putida GPo1 encodes two PHA polymerases and a depolymerase ͑Figure 1͒ ͑Huisman et al. 1991͒. The substrate specificities of these enzymes differ slightly ͑Huis-man et al. 1992͒. The two PHA polymerases are 53% identical. A homologous operon from P. aeruginosa has also been identified ͑Timm and Steinbüchel 1992͒. The corresponding PHA polymerases from P. putida and P. aeruginosa show 69-80% identity at amino acid level ͑Huisman et al. 1991; Timm and Steinbüchel 1992͒. Biosynthesis of these polymers in host organisms that do not naturally produce PHA allows modification of biosynthetic enzymes. This in turn allows increases in the quantity and quality of the products ͑Kidwell et al. 1995͒. In addition, introduction of specific genes into an organism having a suitably modified PHA synthetic pathway may allow extension and regulation of the range of compounds that is produced. Escherichia coli is one of these useful hosts. Indeed, many peptides and proteins of pharmaceutical value have been successfully expressed in recombinant E. coli. Mcl-PHA has also been successfully produced in E. coli by using P. aeruginosa phaC genes ͑Langenbach et al. 1997; Qi et al. 1997͒ and P. putida GPo1 phaC genes ͑Ren 1997; Ren et al. 2000a; Ren et al. 2000b͒ expressed from the Plac promoter. However, there are no reports on the stability and sustainability of heterologous phaC expression systems or high-copy-number plasmids in recombinant E. coli, even though large-scale PHA production requires stable and constant expression of phaC genes.
In this study, we compared expression of the two phaC genes from P. putida in E. coli recombinants, and investigated the stability of different phaC expression systems. Our results demonstrated that the two phaC genes cannot be expressed without an external promoter in E. coli. Stable and regulated expression of phaC genes resulted in the formation of about 20% PHA of total cell dry weight during batch cultivation. Slight differences in the composition of PHA produced with either PhaC1 or PhaC2 were observed. These stable, regulated systems for phaC gene expressions can serve as a first step toward establishing PHA production in recombinant strains. Construction of pBTC1 and pBTC2 (Figure 2 ). pET101 was obtained by inserting the EcoRI-PstI phaC1 fragment from pGEc407 in pUC18. pET101 was then cut with EcoRI and HindIII to obtain a 2.2 kb fragment, which was cloned into the EcoRI and HindIII site of pJRD215, resulting in pET1 ͑Figure 2͒, or inserted into pVLT33, resulting in pBTC1. pET104 ͑Ren et al. 2000a͒ and pET103 contain a HindIII-SphI fragment with phaC2 from pGEc404 in pUC19 and pUC18, respectively. pET105 was derived from pET104 by inserting an EcoRI excised lacI q gene from pCNB5 into pET104. pET2 was obtained by inserting the EcoRI-HindIII fragment with phaC2 from pET103 into pJRD215. Construction of pET2⍀. pMMB24 was cut with HindIII to obtain the transcriptional terminator ⍀, which was then inserted into HindIII digested pET2, resulting in pET2⍀.
Materials and methods

Strains
Media and culture conditions. E. coli was precultured at 37°C in Luria-Bertani ͑LB͒ medium ͑Sambrook et al. 1989͒, then transferred with 1:100 dilution to 0.1NE2 ͑Huisman et al. 1989͒ minimal medium containing 2 mM hexadecanoate and 0.2% yeast extract as co-carbon source. Hexadecanoate stock solutions were prepared as previously described ͑Jenkins and Nunn 1987͒. If necessary, antibiotics were added: kanamycin ͑Km͒, 50 g/ml, ampicillin ͑Ap͒, 150 g/ml, streptomycin ͑Sp͒, 50 g/ml, chloramphenicol ͑Cm͒, 30 g/ml. Cell growth was monitored by measuring optical density at 450 nm ͑OD450͒ ͑Witholt 1972͒. In order to induce the Plac or Ptac promoter, isopropyl-␤-D-thiogalactopyranoside ͑IPTG͒ was added to indicated concentrations in the early exponential phase ͑OD450 about 0.2͒. Samples were taken as described in the results section.
Plasmid stability. To determine the percentage of cells that lost plasmids carrying the ampicillin, streptomycin or kanamycin resistance, cells were serially diluted and plated on LB plates with and without 150 g/ml Ap, 50 g/ml Sp or 50 g/ml Km. The number of colonies was counted after overnight growth, and compared.
Determination of PHA. To determine the polyester content of bacteria, cells were grown in minimal medium cultures as indicated in the results section and assayed for the presence and composition of PHA by gas chromatography ͑GC͒ ͑Lageveen et al. 1988͒. All experiments were carried out 2 or 3 times, and averages of these independent experiments are presented.
Results and discussion
Previously we have reported that deficiency of the fatty acid degradation enzymes FadA or FadB enabled mcl-PHA synthesis in E. coli ͑Ren et al. Figure 3 . Stability of phaC containing plasmids in E. coli. E. coli recombinants JMU193 carrying pET101, pET104, pET105, pBTC1 and pBTC2 were grown on minimal media containing 2 mM hexadecanoate and 0.2% yeast extract with relevant antibiotics ͑ampicillin or kanamycin͒. Colony forming units were then monitored for 36 h.
2000a͒. In this study, the E. coli fadR fadB mutant JMU193 was used. The fadR gene encodes a protein that exerts negative control over genes necessary for fatty acid oxidation ͑Black and DiRusso 1994; DiRusso and Nunn 1985; Jenkins and Nunn 1987; Nunn 1986͒ . A mutation in fadR derepresses transcription of these genes, as a result of which the fad genes are constitutively expressed, rendering E. coli capable of growth on mcl fatty acids ͑Black and DiRusso 1994; DiRusso and Nunn 1985͒. The fadB gene encodes four enzyme activities of the fatty acid oxidation path: enoyl-CoA hydratase, 3-hydroxyacylCoA dehydrogenase, ⌬ 3 -cis-⌬ 2 -trans-enoyl-CoA isomerase, and 3-hydroxyacyl-CoA epimerase ͑Black and DiRusso 1994; DiRusso and Nunn 1985; Jenkins and Nunn 1987; Nunn 1986͒ . Mutations in fadB block fatty acid oxidation and result in the accumulation of specific intermediates, which can be channeled to PHA formation ͑Ren et al. 2000a͒.
PhaC1 and phaC2 expression plasmids. To better understand the consequences of regulated or unregulated phaC1 and phaC2 expression from their native or heterologous promoters in E. coli, we constructed the plasmids listed in Table 1 . Plasmid pET1 contains the native, unmodified phaC1 gene plus the upstream region ͑up to Ϫ 555 bp with respect to the ATG start codon͒ without external promoter ͑Figure 1͒. pET2 contains phaC2 plus the upstream region ͑up to Ϫ 120 bp with respect to the ATG start codon͒ without external promoter ͑Figure 1͒. pET101 and pET104 contain phaC1 and phaC2, respectively, with upstream regions and the genes are expressed from the Plac promoter ͑Table 1͒.
Expression of phaC genes and PHA formation in pha + E. coli. E. coli JMU193 was transformed with the plasmids described above. The transformants were cultivated in minimal medium containing 2 mM hexadecanoate and 0.2% yeast extract as described in 'Material and methods' and samples were analysed for PHA accumulation after 48 h. In E. coli JMU193͓pET1͔, no trace of any of the methyl esters of 3-hydroxyalkanoates ͑ Յ 0.1% PHA of cell dry weight͒ was found ͑Table 1͒, whereas in E. coli JMU193 harbouring pET101, a high copy number plasmid through which phaC1 is constitutively expressed from the Plac promoter ͑i. e. the Plac promoter is not controlled by the monocopy lacI product͒, PHA accumulated to about 26% of the cellular dry matter ͑Table 1͒. Therefore, we conclude that the promoter of phaC1 from P. putida GPo1 is not active in E. coli.
In E. coli JMU193 harbouring pET2, about 5% PHA of total cell dry weight was produced ͑Table 1͒, suggesting that a promoter upstream of phaC2 is active in E. coli. To test this possibility, a transcriptional terminator was inserted into the polylinker region Ϫ 555 bp upstream of phaC2 in pET2, resulting in pET2⍀ ͑Table 1͒. No detectable PHA was found in E. coli JMU193 carrying pET2⍀. Thus, phaC2 is not expressed in E. coli without an external promoter. The reason why 5% PHA was found in JMU193 carrying pET2 could be that a putative foreign promoter ͑such as promoters for antibiotics resistances͒ upstream of phaC2 is present on pET2, in other words, the expression of phaC2 on pET2 in E. coli is not driven by its native promoter but by a putative foreign promoter upstream of phaC2. Compared with pET2, pET1 did not lead to PHA production in recombinant E. coli, even though both phaC1 from pET1 and phaC2 from pET2 are located on the same plasmid. This could be caused by the reversed orientation of the two genes on the plasmid, resulting in that phaC2 could be expressed by a putative foreign promoter, whereas phaC1 could not. When E. coli JMU193 harbouring pET104 constitutive phaC2 expression from the Plac promoter was tested, about 1.2% PHA was formed ͑Table 1͒.
Since each of the phaC genes from P. putida Gpo1 enables PHA synthesis in the PHA negative mutant P. putida GPp104, both genes are likely to have a similar function in the formation of PHA ͑Huisman et al. 1992, Huisman et al. 1991͒ . It has been shown that there is an active promoter upstream of phaC1 in P. putida ͑Huisman et al. 1991͒. A promoter upstream of phaC2 has also been postulated for P. aeruginosa PAO1 ͑Timm and Steinbüchel 1992͒. Furthermore, expression of pET2⍀ in P. putida GPp104 resulted in a PHA accumulation of 9.4% of the total cell dry weight, thereby proving the presence of an active promoter upstream of the phaC2 gene. However, our results demonstrate that these two promoters are not active in E. coli. This is different from the well studied PHB synthetic genes, which are constitutively expressed from their own promoter in E. coli ͑Schubert et al. 1991͒. Since expression of many Pseudomonas genes is positively regulated, and these genes are not transcribed without the corresponding regulatory protein in E. coli ͑Deretic et al. 1989͒, our data indicates that not only the transcription of phaC1 is regulated in P. putida GPo1, as reported previously ͑Prieto et al. 1999͒, but also probably that of phaC2. However, we cannot rule out other possibilities for the failure to obtain phaC2 expression in E. coli, such as that the phaC2 promoter is not recognised by the E. coli RNA polymerase.
Plasmid stability in E. coli recombinants expressing phaC. One possible reason for the lower amount of PHA associated with the high gene dosage in JMU193͓pET104͔ compared to that in JMU193͓pET2͔ could be the loss of the plasmid. Therefore, we investigated the stability of the constructed plasmids. To determine the percentage of cells that lost the antibiotic resistance, the JMU193 recombinants were grown in batch cultures in minimal media supplied with 2 mM hexadecanoate and 0.2% yeast extract in the presence of the selective marker ͑JMU193 carrying pET101 or pET104 with ampicillin, JMU193 carrying pET1 or pET2 with kanamycin͒, and the antibiotic resistance was monitored for approximately 36 h. Cultures were serially diluted and plated on LB plates with and without 150 g/ml ampicillin or 50 g/ml kanamycin. The number of colonies was counted after overnight growth and compared. Plasmids pET1 and pET2 were 100% stable in JMU193 during the tested time period ͑data not shown͒. However, the presence of these plasmids in JMU193 resulted in no or low PHA production ͑Table 1͒. Figure 3 shows that in the JMU193͓pET104͔ culture, 60% of the cells lost the ampicillin resistance within 10 h; while in the JMU193͓pET101͔ culture, 89% of the cells remained ampicillin resistant after 10 h. The above results reveal that although both phaC1 ͑in pET101͒ and phaC2 ͑in pET104͒ were cloned in the same high copy number plasmid and equipped with the same strong promoter ͑Table 1͒, the latter is less stable in E. coli JMU193 ͑Figure 3͒. This difference is probably caused by the different upstream regions of phaC1 in pET101 and phaC2 in pET104 ͑Figure 1͒, or by the nature of the expressed protein.
To test whether uncontrolled expression of phaC2 from pET104 plays a role in the plasmid instability, we constructed pET105 from pET104 ͑Table 1͒. pET105 overproduces the LacI repressor protein to control the expression of phaC2. Under induced conditions, about 77% of the JMU193͓pET105͔ cells remained ampicillin resistant after 10 h growth in minimal media batch culture with hexadecanoate and yeast extract in the presence of ampicillin ͑Figure 3͒. To quantify the PHA content, JMU193͓pET105͔ was cultivated on 0.1NE2 minimal medium with hexadecanoate and yeast extract as described in 'Materials and Methods'. About 11% PHA relative to cell dry weight was obtained from JMU193͓pET105͔ after 48 h ͑Table 1͒, whereas less than 0.1% PHA was found without induction. Therefore, we conclude that uncontrolled overproduction of PHA polymerase in JMU103͓pET104͔ is at least in part responsible for the observed low amount PHA. Regulated expression of phaC2 from pET105 enhanced plasmid stability, which led to enhanced PHA accumulation. The loss of the PHA accumulation phenotype is possibly caused by the segregational instability of pET104 in E. coli JMU193, which could be further increased by the uncontrolled expression of phaC2 from the strong heterologous Plac promoter on a high copy number vector: overproduction of PhaC2 might be toxic to E. coli cells. Subsequently, plasmid-free cells grew faster, allowing them to overgrow the recombinant cell population. This hypothesis was confirmed by using pET105. Although pET105 is also not completely stable in E. coli JMU193 ͑77% of the cells still contained plasmid after 10 hours͒, the increased stability compared to pET104 already allowed E. coli JMU193 to synthesize about 11% PHA upon IPTG induction.
Another reason for the instability of pET101, pET104 and pET105 in JMU193 could be the instability of ampicillin which is degraded in time by E. coli cells ͑Sambrook et al. 1989͒ .
Application of stable plasmids in recombinant E. coli. The results described above show that the high copy number plasmids pET101, pET105 and pET104, all with ampicillin markers, were not stable enough for PHA production. This suggests that the combination of controlled phaC expression from a strong heterologous promoter on low copy number plasmid with another antibiotic marker might be effective in stabilizing PHA production in E. coli. Therefore, we constructed pBTC1 and pBTC2 ͑Fig-ure 2͒, which are derived from a low copy number vector containing the Ptac promoter, a lacI q gene, and a streptomycin marker. As shown in Figure 3 , both pBTC1 and pBTC2 are much more stable than pET101 and pET104 ͑or pET105͒ in E. coli JMU193 when the recombinants were grown in minimal media with hexadecanoate and yeast extract during the tested period. The plasmids were found to be structurally stable as well since the restriction patterns of plasmid DNA isolated during the cultivation were identical to those of the original constructs and they allowed re-transformed JMU193 to accumulate PHA ͑data not shown͒.
PHA accumulation using alternative phaC expression systems. E. coli JMU193 containing pBTC2 yielded more PHA than JMU193 containing pET104 or pET105, as shown in Table 1 . The PHA content was increased from less than 1% without induction to about 20% in response to induction by 100 M IPTG. A similar behaviour was found for JMU193 carrying pBTC1: no detectable PHA was found without induction, while about 17% PHA was formed when the recombinant was induced with 100 M IPTG ͑Table 1͒. Higher IPTG concentrations ͑up to 1 mM͒ had no effect on PHA content or PHA monomer composition in both recombinants.
The PHA content in a host strain depends on the precursor concentration and the polymerase concentration ͑when it is below a certain level͒. The precursor concentration is presumably identical in E. coli recombinants JMU193 carrying pET2, pBTC2 and pET105. Since the PHA content ͑Table 1͒ differed in these E. coli recombinants, these differences must be due to the relative polymerase concentrations. The higher amount of PHA accumulation in JMU193͓pET105͔ ͑about 11% of cell dry weight͒ and JMU193͓pBTC2͔ ͑about 20% of cell dry weight͒ than that found in JMU193͓pET2͔ ͑about 5% of cell dry weight͒ suggests that higher phaC gene dosage can support the accumulation of PHA to a high concentration in recombinant E. coli, which has also been observed for poly-3-hydroxybutyrate ͑PHB͒ synthesis in E. coli ͑Lee and Chang 1995, Lee et al. 1994͒ . In other words, relatively large amounts of enzyme seem to be required to direct the carbon flow from 3-hydroxyalkanoates to PHA synthesis among the several competing metabolic pathways such as continued ß-oxidation ͑Lee and Chang 1995͒. The reason why JMU193͓pBTC1͔ produced less PHA ͑about 17% of cell dry weight͒ than JMU193͓pET101͔ ͑about 26% of cell dry weight͒ might be the higher copy number of pET101 than pBTC1, although in both recombinants, phaC1 is expressed from the strong promoters Plac or Ptac. However, pET101 is not stable in recombinant E. coli ͑Figure 3͒, and thus not suitable for PHA production.
Effect of different phaC genes on the PHA composition. Table 1 shows that when both phaC1 and phaC2 genes are located on the same type of plasmid, the PHA polymers formed by PhaC1 consisted of more C6, similar amounts of C8 and less C10 ͑the molar ratio of C6:C8:C10 is 10:76:14 from pET101, 11:78:11 from pBTC1͒, compared to polymers produced by PhaC2 ͑the molar ratio of C6:C8:C10 is 7:76:17 from pET105, 8:77:15 from pBTC2͒. The PHA monomer composition depends on the precursor concentration, the specificity of the PHA polymerase for each precursor and the polymerase concentration ͑when it is below a certain level͒. The precursor concentration and the enzyme specificity profile are presumably identical in E. coli recombinants JMU193 carrying phaC genes. Since the two genes are located on the same type of vector, these PHA composition differences are not likely to be due to a gene dosage or a substrate concentration effect. Instead, these differences suggest that the polymerases have different substrate specificities. Evidently, PhaC1 has higher affinity to 3-hydroxyhexanoyl-CoA and lower affinity to 3-hydroxydecanoyl-CoA than PhaC2, as was also found for the PHA negative mutant P. putida GPp104 carrying each of these two phaC genes ͑Huisman et al. 1992͒.
Conclusion
In this study, we investigated the expression of two phaC genes from P. putida in E. coli. This led to the observation that significant PHA production in E. coli requires high phaC1/C2 gene expression. However, the loss of the PHA accumulation phenotype occurred in E. coli recombinants when expression of phaC genes was not tightly controlled, which was similar to poly-3-hydroxybutyrate ͑PHB͒ production in E. coli ͑Lee et al. 1994͒. Apparently, phaC-or phbCABcontaining plasmids are lost when they are not vital to growth and impose detrimental effects on the cells. Therefore, for long term PHA production in E. coli, it is necessary to establish a system which allows stable and high PHA production. In the present report we generated a system where phaC expression was controlled by a strong heterologous promoter from low copy number plasmid and reached stable PHA production in E. coli. However, the PHA levels achieved in E. coli recombinants are not yet maximal, compared to that in native and recombinant P. putida where PHA is accumulated to 50-70% of cell dry mass ͑Huisman et al. 1992͒. One possibility is that the supply of PHA precursors is rate-limiting in E. coli, thereby limiting the attainable PHA production. Further experiments should be done to address this possibility.
